Accessibility setting


Select language

Skip to secondary menu

Skip to content

Jehovah’s Witnesses


Perioperative Care

Outcomes (Economic)

Risk-adjusted clinical outcomes in patients enrolled in a bloodless program.

Frank SM, Wick EC, Dezern AE, Ness PM, Wasey JO, Pippa AC, Dackiw E, Resar LMS.

Source‎: Transfusion 2014;54(10 Pt 2):2668-77.

Indexed‎: PubMed 24942198

DOI‎: 10.1111/trf.12752

Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgery.

LaPar DJ, Crosby IK, Ailawadi G, Ad N, Choi E, Spiess BD, Rich JB, Kasirajan V, Fonner E Jr, Kron IL, Speir AM; Investigators for the Virginia Cardiac Surgery Quality Initiative.

Source‎: J Thorac Cardiovasc Surg 2013;145(3):796-804.

Indexed‎: PubMed 23414992

DOI‎: 10.1016/j.jtcvs.2012.12.041

Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery.

Tartter PI, Mohandas K, Azar P, Endres J, Kaplan J, Spivack M.

Source‎: Am J Surg 1998;176(5):462-6.

Indexed‎: PubMed 9874434

Intra-operative cell salvage in South Africa: feasible, beneficial and economical.

Solomon L, von Rahden RP, Allorto NL.

Source‎: S Afr Med J 2013;103(10):754-7.

Indexed‎: PubMed 24079629

DOI‎: 10.7196/samj.7355

Effective reduction of blood product use in a community teaching hospital: when less is more.

Politsmakher A, Doddapaneni V, Seeratan R, Dosik H.

Source‎: Am J Med 2013;126(10):894-902.

Indexed‎: PubMed 24054957

DOI‎: 10.1016/j.amjmed.2013.06.013

Safety, cost savings, simplicity back broader use of bloodless surgery.

Mathias JM.

Source‎: OR Manager 2013;29(5):1, 6, 8-9.

Indexed‎: PubMed 23755462

Economic considerations on transfusion medicine and patient blood management.

Hofmann A, Ozawa S, Farrugia A, Farmer SL, Shander A.

Source‎: Best Pract Res Clin Anaesthesiol 2013;27(1):59-68.

Indexed‎: PubMed 23590916

DOI‎: 10.1016/j.bpa.2013.02.001

Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery.

Irisson E, Hémon Y, Pauly V, Parratte S, Argenson JN, Kerbaul F.

Source‎: Orthop Traumatol Surg Res 2012;98(5):477-83.

Indexed‎: PubMed 22854336

DOI‎: 10.1016/j.otsr.2012.05.002

From blood transfusion to patient blood management: a new paradigm for patient care and cost assessment of blood transfusion practice.

Leahy MF, Mukhtar SA.

Source‎: Intern Med J 2012;42(3):332-8.

Indexed‎: PubMed 22432987

DOI‎: 10.1111/j.1445-5994.2012.02717.x

The volume of returned red blood cells in a large blood salvage program: where does it all go?

Waters JH, Dyga RM, Waters JF, Yazer MH.

Source‎: Transfusion 2011;51(10):2126-32.

Indexed‎: PubMed 21985047

DOI‎: 10.1111/j.1537-2995.2011.03111.x

Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty.

Na HS, Shin SY, Hwang JY, Jeon YT, Kim CS, Do SH.

Source‎: Transfusion 2011;51(1):118-24.

Indexed‎: PubMed 20624257

DOI‎: 10.1111/j.1537-2995.2010.02783.x

Activity-based costs of blood transfusions in surgical patients at four hospitals.

Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR.

Source‎: Transfusion 2010;50(4):753-65.

Indexed‎: PubMed 20003061

DOI‎: 10.1111/j.1537-2995.2009.02518.x

Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction.

Sarode R, Refaai MA, Matevosyan K, Burner JD, Hampton S, Rutherford C.

Source‎: Transfusion 2010;50(2):487-92.

Indexed‎: PubMed 19804569

DOI‎: 10.1111/j.1537-2995.2009.02413.x

An economic analysis of costs associated with development of a cell salvage program.

Waters JR, Meier HH, Waters JH.

Source‎: Anesth Analg 2007;104(4):869-75.

Indexed‎: PubMed 17377098

Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model.

Davies L, Brown TJ, Haynes S, Payne K, Elliott RA, McCollum C.

Source‎: Health Technol Assess 2006;10(44):1-228.

Indexed‎: PubMed 17049141

The medical section of is designed as an informational resource primarily for use by clinicians and other health-care professionals. It provides neither medical advice nor treatment recommendations and does not substitute for an appropriately qualified health-care provider. The clinical literature cited is not published by Jehovah’s Witnesses, but it outlines transfusion-alternative strategies that might be considered. It is the responsibility of each qualified health-care provider to maintain awareness of new information, discuss options for care, and assist patients in making choices in accord with their medical condition, wishes, values, and beliefs. Not all listed strategies are appropriate or acceptable to all patients.

Patients: Always seek the advice of your doctor or other qualified health-care provider regarding medical conditions or treatments. Check with a doctor if you suspect you are ill.

The use of this website is governed by its terms of use.